Correction to: Nonviral Genome Editing Based on a Polymer-Derivatized CRISPR Nanocomplex for Targeting Bacterial Pathogens and Antibiotic Resistance (Bioconjugate Chemistry (2017) 28:4 (957967) DOI: 10.1021/acs.bioconjchem.6b00676);Nonviral Genome Editing Based on a Polymer-Derivatized CRISPR Nanocomplex for Targeting Bacterial Pathogens and Antibiotic Resistance

Bioconjugate Chemistry

Volumn 28, Issue 4, 2017, Pages 957-967

  Kang, Yoo Kyung ^a   Kwon, Kyu ^a   Ryu, Jea Sung ^a   Lee, Ha Neul ^a   Park, Chankyu ^a   Chung, Hyun Jung ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BACTERIA; NUCLEIC ACIDS;

ANTIBIOTICS RESISTANCE; BACTERIAL PATHOGENS; BIOCONJUGATES; MULTIDRUG RESISTANTS; NANOCOMPLEXES; NONVIRAL; PATHOGEN RESISTANCE; RESISTANT BACTERIA; SELECTIVE PRESSURE; TREATMENT METHODS;

GENES;

ANTIBIOTIC AGENT; DOUBLE STRANDED DNA; GUIDE RNA; POLYMER; BACTERIAL PROTEIN; CAS9 ENDONUCLEASE STREPTOCOCCUS PYOGENES; ENDONUCLEASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL GENOME; CELL MEMBRANE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONFOCAL MICROSCOPY; GENE EDITING; GRAM POSITIVE BACTERIUM; MAJOR GENE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PENICILLIN RESISTANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; STREPTOCOCCUS PYOGENES; CRISPR CAS SYSTEM; DRUG EFFECTS; ENZYMOLOGY; GENETICS; METABOLISM; PROCEDURES;

BACTERIAL PROTEINS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-CAS SYSTEMS; ENDONUCLEASES; GENE EDITING; GENOME, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POLYMERS; RNA, GUIDE; STREPTOCOCCUS PYOGENES;

EID: 85018506781     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/acs.bioconjchem.8b00771     Document Type: Erratum

References (52)

1. Wright, G. D. (2014) Something old, something new: revisiting natural products in antibiotic drug discovery Can. J. Microbiol. 60, 147-154 10.1139/cjm-2014-0063
2. Levy, S. B. and Marshall, B. (2004) Antibacterial resistance worldwide: causes, challenges and responses Nat. Med. 10, S122-S129 10.1038/nm1145
3. Neu, H. C. (1992) The crisis in antibiotic resistance Science 257, 1064-1073 10.1126/science.257.5073.1064
4. Bergogne-Bérézin, E., Decreé, D., and Joly-Guillou, M. L. (1993) Opportunistic nosocomial multiply resistant bacterial infections-their treatment and prevention J. Antimicrob. Chemother. 32, 39-47 10.1093/jac/32.suppl-A.39
5. Dzidic, S. and Bedeković, V. (2003) Horizontal gene transfer-emerging multidrug resistance in hospital bacteria Acta Pharmacol. Sin. 24, 519-526
6. Joseph, R. (2009) The evolution of life from other planets part 1: the first earthlings, extraterrestrial horizontal gene transfer, interplanetary genetic messengers J. Cosmol. 1, 100-150
7. Lucas, G. M., Lechtzin, N., Puryear, D. W., Yau, L. L., Flexner, C. W., and Moore, R. D. (1998) Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes Clin. Infect. Dis. 26, 1127-1133 10.1086/520311
8. Whitener, C. J., Park, S. Y., Browne, F. A., Parent, L. J., Julian, K., Bozdogan, B., Appelbaum, P. C., Chaitram, J., Weigel, L. M., and Jernigan, J. et al. 2004, Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure Clin. Infect. Dis. 38, 1049-1055 10.1086/382357
9. Dijkshoorn, L., Nemec, A., and Seifert, H. (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii Nat. Rev. Microbiol. 5, 939-951 10.1038/nrmicro1789
10. Suarez, C., Peña, C., Arch, O., Dominguez, M. A., Tubau, F., Juan, C., Gavaldá, L., Sora, M., Oliver, A., and Pujol, M. et al. 2011, A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition BMC Infect. Dis. 11, 272 10.1186/1471-2334-11-272
11. Wright, G. D. and Sutherland, A. D. (2007) New strategies for combating multidrug-resistant bacteria Trends Mol. Med. 13, 260-267 10.1016/j.molmed.2007.04.004
12. Ventola, C. L. (2015) The antibiotic resistance crisis: part 1: causes and threats P. T. 40, 277-283
13. Wright, G. D. (2016) Antibiotic adjuvants: rescuing antibiotics from resistance Trends Microbiol. 24, 862-871 10.1016/j.tim.2016.06.009
14. Drucker, E. (2013) and Krapfenbauer Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine, K EPMA J. 4, 7 10.1186/1878-5085-4-7
15. Wang, J., Lu, Z., Wientjes, M. G., and Au, J. L. S. (2010) Delivery of siRNA Therapeutics: Barriers and Carriers AAPS J. 12, 492-503 10.1208/s12248-010-9210-4
16. Bouard, D., Alazard-Dany, N., and Cosset, F. L. (2009) Viral vectors: from virology to transgene expression Br. J. Pharmacol. 157, 153-165 10.1038/bjp.2008.349
17. Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., and Trono, D. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 272, 263-267 10.1126/science.272.5259.263
18. Smith, R. A., Miller, T. M., Yamanaka, K., Monia, B. P., Condon, T. P., Hung, G., Lobsiger, C. S., Ward, C. M., McAlonis-Downes, M., and Wei, H. (2006) Antisense oligonucleotide therapy for neurodegenerative disease J. Clin. Invest. 116, 2290-2296 10.1172/JCI25424
19. Thomas, C. E., Ehrhardt, A., and Kay, M. A. (2003) Progress and problems with the use of viral vectors for gene therapy Nat. Rev. Genet. 4, 346-358 10.1038/nrg1066
20. Bråve, A., Ljungberg, K., Wahren, B., and Liu, M. A. (2007) Vaccine delivery methods using viral vectors Mol. Pharmaceutics 4, 18-32 10.1021/mp060098+
21. Bobbin, M. L. and Rossi, J. J. (2016) RNA interference (RNAi)-based therapeutics: delivering on the promise? Annu. Rev. Pharmacol. Toxicol. 56, 103-122 10.1146/annurev-pharmtox-010715-103633
22. Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., and Anderson, D. G. (2014) Non-viral vectors for gene-based therapy Nat. Rev. Genet. 15, 541-555 10.1038/nrg3763
23. Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., and Alvarez, R. et al. 2008, A combinatorial library of lipid-like materials for delivery of RNAi therapeutics Nat. Biotechnol. 26, 561-569 10.1038/nbt1402
24. Jin, L., Zeng, X., Liu, M., Deng, Y., and He, N. (2014) Current progress in gene delivery technology based on chemical methods and nano-carriers Theranostics 4, 240-255 10.7150/thno.6914
25. Patnaik, S. and Gupta, K. C. (2013) Novel polyethylenimine-derived nanoparticles for in vivo gene delivery Expert Opin. Drug Delivery 10, 215-228 10.1517/17425247.2013.744964
26. Sanvicens, N. and Marco, M. P. (2008) Multifunctional nanoparticles-properties and prospects for their use in human medicine Trends Biotechnol. 26, 425-433 10.1016/j.tibtech.2008.04.005
27. Chung, H. J., Hong, C. A., Lee, S. H., Jo, S. D., and Park, T. G. (2011) Reducible siRNA dimeric conjugates for efficient cellular uptake and gene silencing Bioconjugate Chem. 22, 299-306 10.1021/bc100438m
28. Gaj, T., Gersbach, C. A., and Barbas, C. F. (2013) ZFN, TALEN and CRISPR/Cas-based methods for genome engineering Trends Biotechnol. 31, 397-405 10.1016/j.tibtech.2013.04.004
29. Kawahara, A., Hisano, Y., Ota, S., and Taimatsu, K. (2016) Site-specific integration of exogenous genes using genome editing technologies in zebrafish Int. J. Mol. Sci. 17, 727 10.3390/ijms17050727
30. Park, C. Y., Sung, J. J., and Kim, D. W. (2016) Genome editing of structural variations: modeling and gene correction Trends Biotechnol. 34, 548-561 10.1016/j.tibtech.2016.02.011
31. Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., and Marraffini, L. A. et al. 2013, Multiplex genome engineering using CRISPR/Cas systems Science 339, 819-823 10.1126/science.1231143
32. Marraffini, L. A. (2016) The CRISPR-Cas system of Streptococcus pyogenes: function and applications. Streptococcus pyogenes: Basic Biology to Clinical Manifestations (Ferretti, J. J., Stevens, D. L., and Fischetti, V. A., Eds.) University of Oklahoma Health Sciences Center, Oklahoma City.
33. Kim, S., Kim, D., Cho, S. W., Kim, J., and Kim, J. S. (2014) Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins Genome Res. 24, 1012-1019 10.1101/gr.171322.113
34. Gori, J. L., Hsu, P. D., Maeder, M. L., Shen, S., Welstead, G. G., and Bumcrot, D. (2015) Delivery and specificity of CRISPR/Cas9 genome editing technologies for human gene therapy Hum. Gene Ther. 26, 443-451 10.1089/hum.2015.074
35. Sander, J. D. and Joung, J. K. (2014) CRISPR-Cas systems for editing, regulating and targeting genomes Nat. Biotechnol. 32, 347-355 10.1038/nbt.2842
36. Yin, H., Song, C.-Q., Dorkin, J. R., Zhu, L. J., Li, Y., Wu, Q., Park, A., Yang, J., Suresh, S., and Bizhanova, A. et al. 2016, Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo Nat. Biotechnol. 34, 328-333 10.1038/nbt.3471
37. Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., and Liu, D. R. (2014) Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo Nat. Biotechnol. 33, 73-80 10.1038/nbt.3081
38. Wang, M., Zuris, J. A., Meng, F., Rees, H., Sun, S., Deng, P., Han, Y., Gao, X., Pouli, D., and Wu, Q. et al. 2016, Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles Proc. Natl. Acad. Sci. U. S. A. 113, 2868-2873 10.1073/pnas.1520244113
39. Sun, W., Ji, W., Hall, J. M., Hu, Q., Wang, C., Beisel, C. L., and Gu, Z. (2015) Self-assembled DNA nanoclews for the efficient delivery of CRISPR-Cas9 for genome editing Angew. Chem., Int. Ed. 54, 12029-12033 10.1002/anie.201506030
40. Bozzuto, G. and Molinari, A. (2015) Liposomes as nanomedical devices Int. J. Nanomed. 10, 975-999 10.2147/IJN.S68861
41. Lin, G., Zhang, H., and Huang, L. (2015) Smart polymeric nanoparticles for cancer gene delivery Mol. Pharmaceutics 12, 314-321 10.1021/mp500656v
42. Taranejoo, S., Liu, J., Verma, P., and Hourigan, K. (2015) A review of the developments of characteristics of PEI derivatives for gene delivery applications J. Appl. Polym. Sci. 132, 42096 10.1002/app.42096
43. Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., and Marraffini, L. A. (2014) Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials Nat. Biotechnol. 32, 1146-1150 10.1038/nbt.3043
44. Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S., Dohmae, N., Ishitani, R., Zhang, F., and Nureki, O. (2014) Crystal structure of Cas9 in complex with guide RNA and target DNA Cell 156, 935-949 10.1016/j.cell.2014.02.001
45. Shim, M. S. and Kwon, Y. J. (2009) Acid-responsive linear polyethylenimine for efficient, specific, and biocompatible siRNA delivery Bioconjugate Chem. 20, 488-499 10.1021/bc800436v
46. Ren, X., Liu, L., Zhou, Y., Zhu, Y., Zhang, H., Zhang, Z., and Li, H. (2016) Nanoparticle siRNA against BMI-1 with a polyethylenimine-laminarin conjugate for gene therapy in human breast cancer Bioconjugate Chem. 27, 66-73 10.1021/acs.bioconjchem.5b00650
47. Postupalenko, V., Sibler, A. P., Desplancq, D., Nominé, Y., Spehner, D., Schultz, P., Weiss, E., and Zuber, G. (2014) Intracellular delivery of functionally active proteins using self-assembling pyridylthiourea-polyethylenimine J. Controlled Release 178, 86-94 10.1016/j.jconrel.2014.01.017
48. Lu, W. P., Sun, Y., Bauer, M. D., Paule, S., Koenigs, P. M., and Kraft, W. G. (1999) Penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: kinetic characterization of its interactions with β-lactams using electrospray mass spectrometry Biochemistry 38, 6537-6546 10.1021/bi990025e
49. Mady, M., Mohammed, W., El-Guendy, N. M., and Elsayed, A. (2011) Effect of polymer molecular weight on the DNA/PEI polyplexes properties Rom. J. Biophys. 21, 151-165
50. Hibbing, M. E., Fuqua, C., Parsek, M. R., and Peterson, S. B. (2010) Bacterial competition: surviving and thriving in the microbial jungle Nat. Rev. Microbiol. 8, 15-25 10.1038/nrmicro2259
51. Jiang, W., Bikard, D., Cox, D., Zhang, F., and Marraffini, L. A. (2013) RNA-guided editing of bacterial genomes using CRISPR-Cas systems Nat. Biotechnol. 31, 233-239 10.1038/nbt.2508
52. Gomaa, A. A., Klumpe, H. E., Luo, M. L., Selle, K., Barrangou, R., and Beisel, C. L. (2014) Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems mBio 5, e00928-13 10.1128/mBio.00928-13